These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2199188

  • 21. Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence.
    Nelson DS.
    Clin Exp Immunol; 1974 Jan; 16(1):53-62. PubMed ID: 4619779
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer].
    Kato H, Tamai K, Magaya T, Nagai M, Noguchi H, Suehiro Y, Torigoe T.
    Gan No Rinsho; 1985 May; 31(6 Suppl):594-9. PubMed ID: 4032751
    [Abstract] [Full Text] [Related]

  • 23. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix.
    Volgger B, Aspisirengil C, Genser-Krimbacher E, Ciresa-Koenig A, Daxenbichler G, Fuchs D, Windbichler G, Marth C.
    Cancer Lett; 2008 Apr 18; 262(2):183-9. PubMed ID: 18226853
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy.
    Kim BG, Kim JH, Park SY, Lee JH, Lee ED, Lee KH, Park KB, Lee BH, Kim KH.
    Gynecol Oncol; 1996 Oct 18; 63(1):105-13. PubMed ID: 8898178
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Tumor markers in uterine cancers].
    Fukasawa I, Kousaka N, Kun Z, Inaba N.
    Gan To Kagaku Ryoho; 2002 Feb 18; 29(2):333-40. PubMed ID: 11865645
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Blood group antigen expression and prognosis in squamous cell carcinoma of the uterine cervix.
    Lindgren A, Stendahl U, Brodin T, Lundblad A, Sällström J, Busch C.
    Anticancer Res; 1986 Feb 18; 6(2):255-8. PubMed ID: 2423015
    [Abstract] [Full Text] [Related]

  • 33. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V, Kumari TV, Vasudevan DM.
    J Exp Pathol; 1985 Feb 18; 2(2):123-33. PubMed ID: 2431113
    [Abstract] [Full Text] [Related]

  • 34. Clinical significance of assay of squamous cell carcinoma related antigen in tumors of the reproductive organs.
    Takahashi K, Shirai T, Kijima S, Moriyama M, Shibukawa T, Iwanari O, Matsunaga I, Kitao M.
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug 20; 22(7):1304-12. PubMed ID: 3430020
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Metastatic squamous cell carcinoma of the cervix. The role of immunology in its pathogenesis.
    Davidsohn I, Norris HJ, Stejskal R, Lill P.
    Arch Pathol; 1973 Feb 20; 95(2):132-4. PubMed ID: 4683161
    [No Abstract] [Full Text] [Related]

  • 38. [Value of the assay of squamous cell carcinoma in cancer of the uterine cervix].
    Gosselin P, Cazin JL, Dehaut JP, Sulman C, Baranzelli MC, Demaille MC.
    Presse Med; 1987 Oct 17; 16(34):1677-9. PubMed ID: 2959941
    [Abstract] [Full Text] [Related]

  • 39. [Flow cytofluorometric analysis for screening cervical squamous cell carcinoma using specific antibody to a tumor antigen TA-4].
    Nagai M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr 17; 36(4):612-6. PubMed ID: 6715941
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.